Sponsored by: Nebius
Accelerate drug discovery with AI: Nebius & NVIDIA BioNeMo
Drug discovery is often held back by expensive experiments, long training cycles and limited compute power.
In this webinar, you’ll see how NVIDIA BioNeMo, together with Nebius scalable cloud infrastructure, can reduce time and cost by accelerating model training, streamlining inference and powering complex computational biology workloads 👉Register now!
Let’s dive in 👇
If you have only 30 seconds - some of the key updates:
US hospitals remain underprepared for AI governance, with only 29% maintaining formal model inventories.
InterSystems (US) launched a clinical AI assistant that retrieves and summarises patient data conversationally.
My Doctor Friend (US) introduced a patient-side AI copilot offering real-time contextual guidance when clinicians aren’t available.
Vital (US) rolled out a no-login urgent care platform with >94% wait-time accuracy and 60–78% adoption.
Elon Musk claimed Tesla’s Optimus robots will evolve into autonomous surgical systems.
FDA (US) signalled tighter oversight for generative-AI mental-health tools, including risk categories and drift monitoring.
HCA Healthcare (US) expanded Azure-based operational AI across 180+ hospitals.
Cambridge University Hospitals (UK) detailed a full-stack Azure AI architecture with governance and ambient pilots.
No Barrier (US) raised $2.7M for real-time multilingual clinical translation.
If you have more time, read on for the foresight of the week and the full breakdown of what shaped healthcare AI last week👇
Signal of the week
Hospitals are moving from AI pilots to full-stack AI infrastructure
This week, HCA Healthcare (US) reveals its expansion of Azure-driven operational AI across 180+ hospitals, Cambridge University Hospitals (UK) detailed a full Azure-based AI architecture with governance, deployment pipelines and ambient voice pilots, and Spain advanced its national imaging-AI strategy through cancer-screening pilots. Three very different systems - but the same direction of travel.
From speaking with providers across both ends of the spectrum, I’ve seen first-hand how the divide is becoming huge: some hospitals are building structured governance, model inventories and controlled deployment pathways, while others have none - and are quietly panicking as the baseline shifts beneath them.
Foresight:
The race has begun. Over the next 12 months, the competitive gap will be determined by infrastructure and governance - not by who buys the most or best tools.
Solutions and Launches
InterSystems (US): Launched the HealthShare AI Assistant, a conversational tool that retrieves clinical data, surfaces insights and supports clinician engagement. [link]
Vital (US): Launched a no-login urgent care platform that delivers real-time updates, >94% accurate wait times, and personalised guidance via SMS. Early pilots show 60-78% patient adoption and 30-50% reductions in LWOBS/AMA. [link]
My Doctor Friend (US): A patient-side AI copilot launched, providing contextual health explanations to patients in moments where clinicians are inaccessible.[link]
Avicenna.AI (France): Launched AVI, a PACS-integrated platform that surfaces AI findings invisibly within radiologist workflows. It centralises stroke, PE, aortic and spinal models into a single integration point. [link]
Elon Musk: Says Tesla’s Optimus robots will become super surgeons handling complex procedures autonomously in the future.[link]
Governance, Policy, and Ethics
FDA (US): The FDA signalled tighter expectations for generative-AI mental health tools, emphasising clearer risk categories, uncertainty detection, drift monitoring and more robust evidence requirements. [link]
National Academy of Medicine (US): Released a comprehensive AI Code of Conduct outlining responsible development, validation and oversight. It offers health systems a governance blueprint that goes beyond local policies. [link]
EDPS (EU): Issued risk-management guidance for procuring AI systems involving personal data. It reinforces privacy-by-design in sensitive health settings. [link]
Spain: The country approves a national AI strategy for healthcare. Plans include using AI for early cancer detection, with pilots active in Andalusia. This accelerates integration of imaging AI into national screening. [link].
Research and AI Advancements
Google launches Gemini 3: a multimodal reasoning model with deeper contextual understanding and improved intent interpretation. [link]
Report finds healthcare providers underfunding AI governance
Only 29% of US hospitals maintain formal AI inventories or auditing processes, raising compliance and safety concerns. Leaders cite insufficient vendor documentation as a major barrier to deploying AI responsibly. [link]Artificial superintelligence alignment in healthcare
The review warned that advanced, opaque AI systems could destabilise clinical infrastructure if misaligned. It argues for health-specific alignment frameworks to prevent long-term systemic risks. [link]
MAFM^3: Modular Adaptation of Foundation Models for Multi-Modal Medical AI [link]
Partnerships, Collaborations, and Implementations
HCA Healthcare (US): deployed Azure-based AI for staffing and operational forecasting across 180+ hospitals. It has reduced overtime and improved resource allocation. [link]
Matic + Codematic (US):Their AI platform processes 95% of claims error-free. This reduces denials, particularly in behavioural health networks. [link]
Children’s Hospital of Philadelphia + Epic AI Text Assistant (US):
This will simplify complex medical notes into patient-friendly language. It strengthens the intent of OpenNotes by making records accessible to patients. [link]Cambridge University Hospitals + Microsoft / Newton’s Tree (UK):
CUH detailed a full Azure-based AI architecture with an AI deployment platform, governance structures and an ambient voice pilot. It serves as a blueprint for end-to-end clinical AI pipelines. [link]
Bets on the Next Health System
Investments:
No Barrier (US): raises $2.7M seed, developing real-time clinical translation tools for 40+ languages. [link]
Iambic Therapeutics (US): raises $100M Series B (US) to advance three AI-discovered oncology drugs into Phase 2 trials. The funding accelerates their integrated wet-lab and AI pipeline.[link]
Synchron (US) raises $200M Series D to continue clinical trials of its BCI implant for ALS patients. It has FDA breakthrough designation for speech restoration. [link]
Voize (Germany) raised $50M Series A to automate up to 30% of nursing documentation using ambient AI. [link]
Nabta Health (UAE) raises $2M pre-Series A to scale its hybrid AI-powered women’s health model across MEA. It combines digital triage with clinic-based care pathways.[link]
M&ALuma Health + Tonic (US): Acquisition to extend their AI-driven patient access platform to 1,000 health systems, including major Oracle Health EHR customers.[link]
GetWell Network + RhythmX AI (US): The two firms merged under SymphonyAI to unify patient engagement with precision insights.[link]
Radiology Partners + Cognita Imaging (US)- $80M acquisition to boost Mosaic Drafting AI’s performance and expands Cognita’s deployment scale.[link]
That’s a wrap for Edition #6 of Health AI Foresight.
My goal with this newsletter is simple - to connect the present, the emerging, and the future of healthcare AI.
See you next week.
- Dr. Aboufandi
📩 Something stand out? Or have a suggestion? Hit reply - I read every message.